P&G Pharma Asset Exchange For Bristol's Clairol Possible, Analyst Says

Procter & Gamble may be willing to "exchange part or all of its pharmaceutical assets along with cash" to acquire Bristol-Myers Squibb's Clairol business, Merrill Lynch analyst Heather Murren says in a May 4 report.